Mogilansky Christian, Massoudy Parwis, Czesla Markus, Balan Robert
Department of Cardiac Surgery, Klinikum Passau, 94032 Passau, Germany.
J Clin Med. 2023 Mar 6;12(5):2083. doi: 10.3390/jcm12052083.
We have previously reported that the incidence of postoperative conduction disorders, especially left bundle branch block (LBBB), after implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis (Edwards Lifesciences, Irvine, CA, USA), was significantly increased compared with conventional aortic valve replacement. We were now interested in how these disorders behaved at intermediate follow-up.
All 87 patients who had undergone surgical aortic valve replacement (SAVR) using the rapid deployment Intuity™ Elite prosthesis and were shown to have conduction disorders at the time of hospital discharge were followed up after surgery. These patients' ECGs were recorded at least 1 year after surgery, and the persistence of the new postoperative conduction disorders was assessed.
At hospital discharge, 48.1% of the patients had developed new postoperative conduction disorders, with LBBB being the predominant conduction disturbance (36.5%). At medium-term follow-up (526 days, standard deviation (SD) = 169.6, standard error (SE) = 19.3 days, respectively), 44% of the new LBBB and 50% of the new right bundle branch block (RBBB) had disappeared. There was no new atrio-ventricular block III (AVB III) that occurred. One new pacemaker (PM) was implanted during follow-up because of AVB II Mobitz type II.
At medium-term follow-up after the implantation of a rapid deployment Intuity™ Elite aortic valve prosthesis, the number of new postoperative conduction disorders, especially LBBB, has considerably decreased but remains high. The incidence of postoperative AV block III remained stable.
我们之前曾报道,与传统主动脉瓣置换术相比,植入快速部署的Intuity™ Elite主动脉瓣假体(美国加利福尼亚州尔湾市爱德华兹生命科学公司)后,术后传导障碍尤其是左束支传导阻滞(LBBB)的发生率显著增加。我们现在感兴趣的是这些障碍在中期随访中的表现。
对所有87例使用快速部署的Intuity™ Elite假体进行外科主动脉瓣置换术(SAVR)且在出院时被证实存在传导障碍的患者进行术后随访。这些患者在术后至少1年记录心电图,并评估新出现的术后传导障碍的持续情况。
出院时,48.1%的患者出现了新的术后传导障碍,其中LBBB是主要的传导紊乱(36.5%)。在中期随访(分别为526天,标准差(SD)=169.6,标准误(SE)=19.3天)时,44%的新发LBBB和50%的新发右束支传导阻滞(RBBB)消失。没有新出现的三度房室传导阻滞(AVB III)。随访期间因二度莫氏II型房室传导阻滞植入了1台新的起搏器(PM)。
在植入快速部署的Intuity™ Elite主动脉瓣假体后的中期随访中,新出现的术后传导障碍尤其是LBBB的数量已大幅减少,但仍处于较高水平。术后AVB III的发生率保持稳定。